HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Trabedersen

TGF-beta2 inhibitor antisense therapeutic for tumor treatment
Also Known As:
AP 12009; AP-2-09
Networked: 14 relevant articles (6 outcomes, 10 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Jachimczak, Piotr: 6 articles (12/2011 - 01/2005)
2. Bogdahn, Ulrich: 5 articles (12/2011 - 01/2005)
3. Hau, Peter: 5 articles (12/2011 - 01/2005)
4. Schlingensiepen, Karl-Hermann: 5 articles (12/2011 - 01/2005)
5. Schlingensiepen, Reimar: 3 articles (01/2007 - 01/2005)
6. Schneider, Anneliese: 2 articles (12/2011 - 06/2011)
7. Schlaier, Jürgen: 2 articles (12/2011 - 01/2007)
8. Jaschinski, Frank: 2 articles (12/2011 - 06/2011)
9. Ludwig, S: 2 articles (01/2011 - 01/2008)
10. Schmaus, S: 2 articles (01/2011 - 01/2008)

Related Diseases

1. Glioma (Gliomas)
2. Brain Neoplasms (Brain Tumor)
3. Adenocarcinoma
4. Neoplasms (Cancer)
5. Astrocytoma (Pilocytic Astrocytoma)

Related Drugs and Biologics

1. Transforming Growth Factor beta2
2. Carcinoembryonic Antigen
3. Trabedersen
4. Messenger RNA (mRNA)
5. Transforming Growth Factor beta (TGF-beta)
6. Vincristine (Oncovin)
7. Fibroblast Growth Factor 7
8. Teriparatide (Parathar)
9. Amlodipine (Norvasc)
10. Arachidonic Acid (Vitamin F)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Immunotherapy
3. Heterologous Transplantation (Xenotransplantation)
4. Therapeutics